| 1 | female gonad development (GO:0008585) | 9.19215792 |
| 2 | regulation of telomere maintenance via telomerase (GO:0032210) | 8.20713356 |
| 3 | inner mitochondrial membrane organization (GO:0007007) | 7.38965885 |
| 4 | cranial suture morphogenesis (GO:0060363) | 7.21849681 |
| 5 | male meiosis (GO:0007140) | 7.18746199 |
| 6 | stress granule assembly (GO:0034063) | 6.75648986 |
| 7 | central nervous system neuron axonogenesis (GO:0021955) | 6.75446807 |
| 8 | negative regulation of telomere maintenance (GO:0032205) | 6.57634066 |
| 9 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 6.34657856 |
| 10 | response to hepatocyte growth factor (GO:0035728) | 6.34657856 |
| 11 | thyroid hormone generation (GO:0006590) | 6.32308745 |
| 12 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 6.28052743 |
| 13 | peptidyl-lysine dimethylation (GO:0018027) | 6.11828937 |
| 14 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 6.11433726 |
| 15 | regulation of protein glycosylation (GO:0060049) | 6.02976618 |
| 16 | positive regulation of keratinocyte differentiation (GO:0045618) | 6.00407565 |
| 17 | regulation of G0 to G1 transition (GO:0070316) | 5.98672625 |
| 18 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 5.89379986 |
| 19 | DNA strand renaturation (GO:0000733) | 5.67489510 |
| 20 | apoptotic DNA fragmentation (GO:0006309) | 5.62856611 |
| 21 | lipid translocation (GO:0034204) | 5.59754175 |
| 22 | phospholipid translocation (GO:0045332) | 5.59754175 |
| 23 | centrosome duplication (GO:0051298) | 5.57585671 |
| 24 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.49236658 |
| 25 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.49236658 |
| 26 | thyroid hormone metabolic process (GO:0042403) | 5.15280412 |
| 27 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.09382859 |
| 28 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.09382859 |
| 29 | intermediate filament cytoskeleton organization (GO:0045104) | 4.92674688 |
| 30 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.92046168 |
| 31 | intermediate filament-based process (GO:0045103) | 4.79819996 |
| 32 | heart trabecula morphogenesis (GO:0061384) | 4.75165474 |
| 33 | mitotic G2 DNA damage checkpoint (GO:0007095) | 4.74592246 |
| 34 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.66540673 |
| 35 | regulation of sister chromatid cohesion (GO:0007063) | 4.64579711 |
| 36 | craniofacial suture morphogenesis (GO:0097094) | 4.54427363 |
| 37 | vitamin transmembrane transport (GO:0035461) | 4.46019249 |
| 38 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.45184080 |
| 39 | maintenance of protein location in nucleus (GO:0051457) | 4.36936955 |
| 40 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.36229097 |
| 41 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 4.35706624 |
| 42 | galactose metabolic process (GO:0006012) | 4.28769248 |
| 43 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 4.23629990 |
| 44 | trabecula morphogenesis (GO:0061383) | 4.21680328 |
| 45 | embryonic heart tube development (GO:0035050) | 4.17778195 |
| 46 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 4.16276042 |
| 47 | viral protein processing (GO:0019082) | 4.14426665 |
| 48 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.07332316 |
| 49 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 4.04920182 |
| 50 | regulation of histone phosphorylation (GO:0033127) | 3.99305072 |
| 51 | negative regulation of receptor activity (GO:2000272) | 3.97938532 |
| 52 | mitotic G2/M transition checkpoint (GO:0044818) | 3.91555172 |
| 53 | protein-cofactor linkage (GO:0018065) | 3.88323728 |
| 54 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.78340208 |
| 55 | androgen biosynthetic process (GO:0006702) | 3.73893995 |
| 56 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.71378836 |
| 57 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.69191838 |
| 58 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.69191838 |
| 59 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.69191838 |
| 60 | outer ear morphogenesis (GO:0042473) | 3.67369966 |
| 61 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.65704815 |
| 62 | intracellular protein transmembrane import (GO:0044743) | 3.63629753 |
| 63 | natural killer cell activation (GO:0030101) | 3.58086736 |
| 64 | mast cell activation (GO:0045576) | 3.52043001 |
| 65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51503701 |
| 66 | regulation of telomere maintenance (GO:0032204) | 3.48341840 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.47092941 |
| 68 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46253150 |
| 69 | reactive oxygen species biosynthetic process (GO:1903409) | 3.44555646 |
| 70 | middle ear morphogenesis (GO:0042474) | 3.41495022 |
| 71 | RNA destabilization (GO:0050779) | 3.41469330 |
| 72 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 3.41096863 |
| 73 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.40557522 |
| 74 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 3.28546636 |
| 75 | regulation of membrane lipid distribution (GO:0097035) | 3.28106990 |
| 76 | replication fork processing (GO:0031297) | 3.27334779 |
| 77 | cell migration involved in heart development (GO:0060973) | 3.25010645 |
| 78 | vitamin transport (GO:0051180) | 3.24112278 |
| 79 | megakaryocyte development (GO:0035855) | 3.19374233 |
| 80 | peptidyl-lysine methylation (GO:0018022) | 3.17422051 |
| 81 | mammary gland epithelial cell proliferation (GO:0033598) | 3.16843064 |
| 82 | endocardial cushion morphogenesis (GO:0003203) | 3.16333410 |
| 83 | regulation of keratinocyte proliferation (GO:0010837) | 3.14720243 |
| 84 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.13399082 |
| 85 | response to thyroid hormone (GO:0097066) | 2.94119611 |
| 86 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87082885 |
| 87 | acrosome assembly (GO:0001675) | 2.86749350 |
| 88 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.82466825 |
| 89 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.81266131 |
| 90 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.79658862 |
| 91 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.76535934 |
| 92 | embryonic hindlimb morphogenesis (GO:0035116) | 2.75721849 |
| 93 | superoxide anion generation (GO:0042554) | 2.75161331 |
| 94 | regulation of keratinocyte differentiation (GO:0045616) | 2.73103746 |
| 95 | neurofilament cytoskeleton organization (GO:0060052) | 18.2345407 |
| 96 | regulation of DNA methylation (GO:0044030) | 14.7965204 |
| 97 | ectoderm development (GO:0007398) | 11.7002238 |
| 98 | glyoxylate metabolic process (GO:0046487) | 11.4155188 |
| 99 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 11.1130005 |
| 100 | chaperone-mediated protein transport (GO:0072321) | 11.0269388 |
OR7E33P 
